See more : Hastings Technology Metals Limited (AUG.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Shanghai Kindly Medical Instruments Co., Ltd. (1501.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Shanghai Kindly Medical Instruments Co., Ltd., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Stem Cell Authority, Ltd. (SCAL) Income Statement Analysis – Financial Results
- Monumental Residence – Sociedade Especial de Investimento Imobiliario de Capital Fixo, SICAFI, S.A. (MLMR.LS) Income Statement Analysis – Financial Results
- TrueContext Corporation (PPRRF) Income Statement Analysis – Financial Results
- Castle Alternative Invest AG (CASN.SW) Income Statement Analysis – Financial Results
- LG HelloVision Corp. (037560.KS) Income Statement Analysis – Financial Results
Shanghai Kindly Medical Instruments Co., Ltd. (1501.HK)
About Shanghai Kindly Medical Instruments Co., Ltd.
Shanghai Kindly Medical Instruments Co., Ltd. engages in the research and development, manufacture, and sale of cardiovascular interventional medical devices in Mainland China, Europe, the United States, and internationally. The company offers interventions products, which includes guiding catheter used to provide a channel for introducing balloon catheter, guidewire or other treatment devices; micro catheter to support the placement of guide wires; guidewire used in percutaneous transluminal angioplasty (PTA) surgical procedures; angiography catheter used to inject and infuse contrast media and fluid; and Y-connector pack used in PTCA surgery. It also provides inflation device used to inflate the balloon of dilating the vessel or placing the stent in the vessel; manifold for single use; manifold kit; pressure bandage used to assist compression hemostasis; angiography syringe for single use; stopcocks used for pressure monitoring tubing during surgery; sterile seldinger needle used to puncture into the artery; introducer set; pressure transducer for single use; extension tube for pressure monitoring; and introducer tool kit used in percutaneous vertebroplasty. In addition, the company offers medical accessories, such as check value, needle free connector, male Luer locks, bi-stopper, Heparian cap, flush device, and flow regulator; other products, including joint intervention kit, disposable respirator masks, vaginal dilator used during a vaginal examination, foley catheter, infusion pumps, disposable automatic umbilical cord clamps, infusion connector and accessory for single use, and burette infusion sets without a needle. It serves medical device manufacturers and other customers. The company was founded in 2006 and is headquartered in Shanghai, China. Shanghai Kindly Medical Instruments Co., Ltd. is a subsidiary of Shanghai Kindly Enterprise Development Group Co., Ltd.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
---|---|---|---|---|---|---|---|---|
Revenue | 752.84M | 585.88M | 464.68M | 358.43M | 286.46M | 203.06M | 137.55M | 106.45M |
Cost of Revenue | 314.77M | 253.40M | 188.93M | 124.01M | 112.02M | 84.66M | 59.76M | 47.44M |
Gross Profit | 438.07M | 332.49M | 275.75M | 234.42M | 174.44M | 118.40M | 77.80M | 59.01M |
Gross Profit Ratio | 58.19% | 56.75% | 59.34% | 65.40% | 60.90% | 58.31% | 56.56% | 55.43% |
Research & Development | 125.85M | 99.63M | 89.96M | 64.59M | 30.76M | 22.10M | 12.92M | 10.88M |
General & Administrative | 99.43M | 64.29M | 49.05M | 35.97M | 34.18M | 20.50M | 11.49M | 10.48M |
Selling & Marketing | 67.40M | 56.39M | 30.02M | 21.48M | 23.96M | 17.60M | 8.60M | 6.10M |
SG&A | 166.82M | 121.61M | 79.64M | 57.44M | 58.13M | 38.10M | 20.09M | 16.57M |
Other Expenses | -32.92M | -270.00K | 1.22M | -3.07M | -4.66M | -236.00K | 680.00K | 995.00K |
Operating Expenses | 259.75M | 200.61M | 133.95M | 121.33M | 84.24M | 53.43M | 30.64M | 25.14M |
Cost & Expenses | 574.51M | 454.01M | 322.88M | 245.35M | 196.25M | 138.09M | 90.40M | 72.58M |
Interest Income | 11.83M | 12.59M | 13.89M | 24.00M | 9.95M | 3.86M | 2.93M | 2.99M |
Interest Expense | 3.19M | 818.00K | 633.00K | 92.00K | 1.83M | 1.53M | 0.00 | 0.00 |
Depreciation & Amortization | 47.55M | 37.08M | 30.22M | 21.96M | 18.64M | 10.94M | 7.14M | 6.03M |
EBITDA | 225.88M | 159.99M | 168.81M | 143.23M | 132.38M | 78.94M | 54.97M | 40.90M |
EBITDA Ratio | 30.00% | 27.31% | 36.33% | 39.96% | 44.89% | 39.84% | 40.19% | 42.52% |
Operating Income | 178.32M | 129.34M | 144.64M | 125.35M | 113.74M | 68.00M | 47.73M | 39.35M |
Operating Income Ratio | 23.69% | 22.08% | 31.13% | 34.97% | 39.71% | 33.49% | 34.70% | 36.97% |
Total Other Income/Expenses | -3.19M | 15.13M | 11.05M | 11.74M | 18.24M | 359.00K | 0.00 | 4.49M |
Income Before Tax | 175.13M | 144.47M | 155.69M | 137.09M | 111.91M | 66.47M | 47.73M | 39.35M |
Income Before Tax Ratio | 23.26% | 24.66% | 33.51% | 38.25% | 39.07% | 32.74% | 34.70% | 36.97% |
Income Tax Expense | 21.90M | 10.64M | 15.25M | 20.57M | 15.38M | 8.24M | 6.96M | 5.35M |
Net Income | 156.46M | 131.71M | 142.96M | 121.35M | 99.61M | 58.45M | 40.77M | 34.00M |
Net Income Ratio | 20.78% | 22.48% | 30.77% | 33.86% | 34.77% | 28.79% | 29.64% | 31.94% |
EPS | 0.94 | 0.79 | 0.86 | 0.73 | 0.79 | 0.37 | 0.25 | 0.21 |
EPS Diluted | 0.92 | 0.78 | 0.86 | 0.73 | 0.79 | 0.37 | 0.25 | 0.21 |
Weighted Avg Shares Out | 165.87M | 167.27M | 166.00M | 166.00M | 126.68M | 160.00M | 160.00M | 160.00M |
Weighted Avg Shares Out (Dil) | 170.86M | 168.40M | 166.80M | 166.00M | 126.68M | 160.00M | 160.00M | 160.00M |
Source: https://incomestatements.info
Category: Stock Reports